Angiotensin converting enzyme inhibitors and angiotensin receptor blockers improved the outcome of patients with severe COVID-19 and hypertension

Benzer Materyaller

• Usage of Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker in Hypertension Intracerebral Hemorrhage
  Yazar:: Zhang, Chao, ve diğerleri
  Baskı/Yayın Bilgisi: (2021)
• Angiotensin converting enzyme inhibitors and angiotensin receptor blockers
  Yazar:: Shrimpton, A.J., ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension
  Yazar:: Li, Edmond CK, ve diğerleri
  Baskı/Yayın Bilgisi: (2014)
• Angiotensin‐Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in African‐American Patients With Hypertension
  Yazar:: Papademetriou, Vasilios, ve diğerleri
  Baskı/Yayın Bilgisi: (2007)
• Angiotensin converting enzymes inhibitors or angiotensin receptor blockers should be continued in COVID-19 patients with hypertension
  Yazar:: Tian, Ci, ve diğerleri
  Baskı/Yayın Bilgisi: (2021)